Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000012762 | SCV002154353 | pathogenic | Glycine encephalopathy | 2023-10-10 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 564 of the GLDC protein (p.Ser564Ile). This variant is present in population databases (rs121964974, gnomAD 0.2%). This missense change has been observed in individual(s) with glycine encephalopathy and/or nonketotic hyperglycinemia (PMID: 1634607, 27362913). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 11982). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GLDC protein function. Experimental studies have shown that this missense change affects GLDC function (PMID: 1634607, 15192636, 15236413, 15824356). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000012762 | SCV003828287 | likely pathogenic | Glycine encephalopathy | 2021-11-23 | criteria provided, single submitter | clinical testing | |
OMIM | RCV004566730 | SCV000032997 | pathogenic | Glycine encephalopathy 1 | 1992-07-01 | no assertion criteria provided | literature only | |
Gene |
RCV000012762 | SCV000086735 | pathologic | Glycine encephalopathy | 2013-07-11 | no assertion criteria provided | curation | Converted during submission to Pathogenic. |